The etiology of poststroke-depression: a hypothesis involving HPA axis

Biomed Pharmacother. 2022 Jul:151:113146. doi: 10.1016/j.biopha.2022.113146. Epub 2022 May 26.

Abstract

Approximately, one in three ischemic stroke survivors suffered from depression, namely, post-stroke depression (PSD). PSD affects functional rehabilitation and may lead to poor quality of life of patients. There are numerous explanations about the etiologies of PSD. Here, we speculated that PSD are likely to be the result of specific changes in brain pathology. We hypothesized that the stroke-induced hyperactivity of hypothalamic-pituitary-adrenal (HPA) axis plays an important role in PSD. Stroke initiates a complex sequence of events in neuroendocrine system including HPA axis. The HPA axis is involved in the pathophysiology of depression, especially, the overactivity of the HPA axis occurs in major depressive disorder. This review summarizes the possible etiologies of PSD, focusing on the stroke-induced activation of HPA axis, mainly including the stress followed by severe brain damage and the proinflammatory cytokines release. The role of hyperactive of HPA axis in PSD was discussed in detail, which includes the role of high level corticotropin-releasing hormone in PSD, the effects of glucocorticoids on the alterations in specific brain structures, the expression of enzymes, excitotoxicity, the change in intestinal permeability, and the activation of microglia. The relationship between neuroendocrine regulation and inflammation was also described. Finally, the therapy of PSD by regulating HPA axis, neuroendocrine, and immunity was discussed briefly. Nevertheless, the change of HPA axis and the occurring of PSD maybe interact and promote on each other, and future investigations should explore this hypothesis in more depth.

Keywords: Corticosteroids; Cytokines; HPA axis; Post-stroke depression; Stress.

Publication types

  • Review

MeSH terms

  • Depression / metabolism
  • Depressive Disorder, Major* / metabolism
  • Humans
  • Hypothalamo-Hypophyseal System / metabolism
  • Pituitary-Adrenal System / metabolism
  • Quality of Life
  • Stroke* / metabolism